MENU
+Compare
CATX
Stock ticker: ASE
AS OF
Jun 5, 04:59 PM (EDT)
Price
$3.14
Change
+$0.01 (+0.32%)
Capitalization
751.25M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CATX with price predictions
Jun 04, 2025

CATX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CATX turned positive on June 03, 2025. Looking at past instances where CATX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 03, 2025. You may want to consider a long position or call options on CATX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CATX moved above its 50-day moving average on May 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CATX crossed bullishly above the 50-day moving average on May 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where CATX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where CATX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CATX broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.990) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.423) is also within normal values, averaging (42.393).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CATX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 15.76% to -28 cents per share on August 08

Perspective Therapeutics CATX Stock Earnings Reports
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
Q3'24
Est.
$-0.21
Q2'24
Missed
by $0.16
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 685.03K shares outstanding, the current market capitalization sits at 751.25M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USGLX64.09N/A
N/A
JHancock U.S. Global Leaders Growth A
WPSIX54.33N/A
N/A
AB Concentrated Growth I
STRAX32.16N/A
N/A
Sterling Capital Behav Lg Cp Val Eq R6
GQLIX33.44N/A
N/A
GMO Quality I
MEGMX14.11N/A
N/A
Matthews Emerging Markets Equity Inv

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+1.29%
STRR - CATX
88%
Closely correlated
+4.09%
SHC - CATX
34%
Loosely correlated
+0.65%
DHR - CATX
31%
Poorly correlated
+0.53%
MTD - CATX
30%
Poorly correlated
+0.28%
FLGT - CATX
29%
Poorly correlated
+0.57%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+1.29%
CATX
(2 stocks)
92%
Closely correlated
-0.21%